Urinary Stone Management During COVID-19 Pandemic

Document Type : Editorial


1 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Pathology, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran


Nowadays, Coronavirus disease 2019 (COVID-19) is a major health problem worldwide. So, regarding the highly recommended homestay strategies for preventing COVID-19, the usual treatment platform for several diseases has changed. During self-quarantine, the urolithiasis treatment is completely different. However, we can suggest conservative treatment for three months during the COVID-19 outbreak, and after that, a reevaluation of the patient will be done. Thus, the operation could be chosen carefully based on the patient's and urologist’s preferences and the infection rate in that center.


  • COVID-19 is a significant health problem all over the world.
  • Many countries used a lockdown strategy to control the COVID-19 outbreak.
  • There were 29,404,719 COVID-confirmed cases around the globe.


Editorial: Coronavirus disease 2019 (COVID-19) is now the major health concern of the century in several countries (1). Due to official data, on 15 September 2020, there were 29,404,719 confirmed cases around the globe, 23,220 deaths, and 404,648 confirmed cases in Iran (2). Many countries used a lockdown strategy to control this outbreak. Many urological wards postponed surgeries to accommodate infected patients. Operations are limited to urological emergencies, and almost all major centers have suspended non-emergent urinary stone surgeries. On the other hand, the prolonged homestay has various undesirable consequences on people, such as physical inactivity and weight gain, which potentially could put the general population at risk of urinary stone formation (1). Besides, fear of COVID-19 can postpone Double-J (DJ) stents removal, raising the risk of encrustation.

Regarding the prevention and treatment strategy of urinary stones in this COVID-19 crisis, we can divide patients into two groups. The first group is the people for whom the urological intervention is not indicated. This group includes normal and at-risk populations and non-struvite, non-cystine renal stones less than 7 mm with no anatomic abnormalities. In this group, general dietary and lifestyle modifications are helpful, which include consuming more than 3 liters of water and beverages each day, restricting the use of salt and red meats, and having home exercise more than three times a week (3).

The second group is the patients for whom the urological intervention is indicated. This group can be divided into emergent and non-emergent subgroups. Patients with urinary stones and concomitant uremia, sepsis, anuria, or refractory pain and vomiting are emergent ones, that intervention is necessary. The preferred option during the novel coronavirus crisis in these patients is percutaneous nephrostomy insertion under local anesthesia. This method is less invasive, and the health provider has less exposure to the patient than DJ stent insertion.

The last subgroup is the patients with asymptomatic and non-complicated urinary stones, in which urologic intervention is indicated at the usual time. However, we can suggest conservative treatment for three months during the COVID-19 outbreak, and after that, a reevaluation of the patient will be done. Shaoqing Lei et al. reported 20% mortality for patients who operated during the incubation period of COVID-19. Despite that, we can leave the operation option for patients who can’t tolerate pain. Thus, the operation could be chosen carefully based on patients' and urologist’s preferences and the rate of infection in that center, However, we do not recommend laparoscopic stone removal due to general anesthesia requirements.



All in all, there is no clear guideline for managing kidney stones during the COVID-19 pandemic. However, we can suggest to all at-risk patients to evaluate for urinary stones after the lockdown period with ultrasonography.


 Authors’ Contribution

All authors had an equal contribution.



Special thanks to the Urology Research Center (URC), Tehran University of Medical Sciences (TUMS).


Conflict of interest

All authors declare that there is not any kind of conflict of interest.



There is no funding.


Ethical statement

Not applicable.


Data availability

Not applicable.



COVID-19       Coronavirus disease 2019

DJ                     Double-J               


1. Lippi G, Henry BM, Bovo C, Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis. 2020 May 26;7(2):85-90.
2. WHO Coronavirus Disease (COVID-19) Dashboard. 2020. URL: https://covid19.who.int/.
3. C. Türk (Chair), A. Neisius, A. Petrik, C. Seitz, A. Skolarikos (Vice-chair), K. Thomas, N.F. Davis, J.F. Donaldson, R. Lombardo, N. Grivas, Y. Ruhayel, members of the EAU urolithiasis Guidelines Panel. EAU Guidelines on urolithiasis. Retrieved from: https://uroweb.org/guideline/urolithiasis/